Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna (NASDAQ:MRNA) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $635,317 and 9, calls, for a total amount of $600,368.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $175.0 for Moderna, spanning the last three months.
Analyzing Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Moderna's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Moderna's substantial trades, within a strike price spectrum from $100.0 to $175.0 over the preceding 30 days.
Moderna Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | PUT | SWEEP | NEUTRAL | 06/28/24 | $7.05 | $7.0 | $7.0 | $125.00 | $363.3K | 0 | 519 |
MRNA | CALL | SWEEP | BEARISH | 05/17/24 | $24.45 | $22.75 | $23.6 | $104.00 | $136.8K | 159 | 79 |
MRNA | CALL | SWEEP | BEARISH | 07/19/24 | $4.65 | $4.6 | $4.6 | $145.00 | $98.4K | 11.4K | 293 |
MRNA | PUT | SWEEP | BEARISH | 06/28/24 | $8.95 | $8.65 | $8.91 | $128.00 | $89.2K | 0 | 100 |
MRNA | CALL | TRADE | BEARISH | 06/20/25 | $15.35 | $14.8 | $14.8 | $175.00 | $81.4K | 0 | 61 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Moderna
- Currently trading with a volume of 1,671,221, the MRNA's price is up by 0.02%, now at $128.34.
- RSI readings suggest the stock is currently may be overbought.
- Anticipated earnings release is in 78 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
有大量資金可以花的大戶對Moderna採取了明顯的看漲立場。
查看Moderna(NASDAQ:MRNA) 的期權歷史記錄,我們發現了17筆交易。
如果我們考慮每筆交易的具體情況,可以準確地說,有41%的投資者以看漲的預期開盤,41%的投資者持看跌預期。
在已發現的全部交易中,有8筆是看跌期權,總額爲635,317美元,9筆看漲期權,總額爲600,368美元。
目標價格是多少?
在評估了交易量和未平倉合約之後,很明顯,主要市場走勢者正在關注過去三個月中Moderna在100.0美元至175.0美元之間的價格區間。
分析交易量和未平倉合約
評估交易量和未平倉合約是期權交易的戰略步驟。這些指標揭示了指定行使價下Moderna期權的流動性和投資者對Moderna期權的興趣。即將發佈的數據可視化了與Moderna的大量交易相關的看漲期權和看跌期權的交易量和未平倉合約的波動,在過去30天內,行使價範圍從100.0美元到175.0美元不等。
Moderna 看漲期權和看跌交易量:30 天概覽
發現的最大選擇:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | PUT | SWEEP | NEUTRAL | 06/28/24 | $7.05 | $7.0 | $7.0 | $125.00 | $363.3K | 0 | 519 |
MRNA | CALL | SWEEP | BEARISH | 05/17/24 | $24.45 | $22.75 | $23.6 | $104.00 | $136.8K | 159 | 79 |
MRNA | CALL | SWEEP | BEARISH | 07/19/24 | $4.65 | $4.6 | $4.6 | $145.00 | $98.4K | 11.4K | 293 |
MRNA | PUT | SWEEP | BEARISH | 06/28/24 | $8.95 | $8.65 | $8.91 | $128.00 | $89.2K | 0 | 100 |
MRNA | CALL | TRADE | BEARISH | 06/20/25 | $15.35 | $14.8 | $14.8 | $175.00 | $81.4K | 0 | 61 |
關於 Moderna
Moderna是一家商業階段的生物技術公司,成立於2010年,並於2018年12月進行了首次公開募股。該公司的 mRNA 技術通過其 COVID-19 疫苗迅速得到驗證,該疫苗於 2020 年 12 月在美國獲得授權。截至2023年中期,Moderna在臨床試驗中有39個mRNA開發候選藥物。項目涵蓋廣泛的治療領域,包括傳染病、腫瘤學、心血管疾病和罕見遺傳病。
在對圍繞Moderna的期權交易進行了全面審查之後,我們將對該公司進行更詳細的審查。這包括評估其當前的市場狀況和表現。
Moderna 目前的市場地位
期權交易帶來更高的風險和潛在的回報。精明的交易者通過不斷自我教育、調整策略、監控多個指標以及密切關注市場走勢來管理這些風險。通過Benzinga Pro的實時提醒,隨時了解最新的Moderna期權交易。